Lumida
/CE
⌘K
Celanese Corp

Celanese Corp

CE
$45.70USD-0.17%-0.08 today

MARKET CAP

5.0B

P/E (TTM)

10.6x

FWD P/E

6.9x

DAY RANGE

$45 – $47

52W RANGE

$35
$71

AI Summary

Stalk
Sell NowHigh

CE remains entrenched in a Stage 4 decline, confirmed by the active Support Failure pattern and a clear sequence of lower highs and lower lows. Price continues to trade below the 9-, 21-, 50-, and 200-day moving averages, with rallies into the EMAs repeatedly rejected. Despite extreme oversold readings, there is no visible exhaustion, and downside momentum looks set to continue. Execution should focus on selling into retracements back toward the declining EMAs.

  • Projects EPS gain of $1–2 in 2026 on strict cost savings.
  • Implements $30M in annual cost reductions to boost margins.
  • Revenue fell 10% YoY to $500M amid weak end-market demand.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Celanese Corporation (NYSE: CE) is a global leader in the specialty materials and chemical sectors, primarily known for its engineered materials and acetyl products. The company serves diverse markets, including automotive, consumer goods, and construction, leveraging its innovative capabilities to meet evolving customer needs. Celanese is currently navigating challenges posed by fluctuating raw material costs and competitive pressures, while strategically focusing on cash generation and operational efficiency to maintain its market position.

Bull says

  • Projects EPS gain of $1–2 in 2026 on strict cost savings.
  • Implements $30M in annual cost reductions to boost margins.
  • Free cash flow forecast of $700–800M for 2026 supports dividends.
  • Dividend yield ~0.75% and solid leverage enhance total returns.
  • Bio-based product push taps growing sustainability markets.
  • Analyst revisions trending up, signaling positive earnings outlook.

Bear says

  • Revenue fell 10% YoY to $500M amid weak end-market demand.
  • Operating margin contracted to 12% from 15% YoY on cost pressures.
  • Profitability factor is negative, indicating efficiency challenges.
  • Growth factor is negative, casting doubt on revenue expansion.
  • High leverage raises balance-sheet risk if markets worsen.
  • Supply chain disruptions and commodity swings heighten earnings risk.

Investment themes with CE

Petrochemicals +1.07%

OEC · DOW · LYB
Specialty Chemical +0.35%

ECL · ALB · IFF
GS: Bad Pricing Power -0.38%

Companies with weak ability to set prices

DDS · PENN · VAC

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-09-2026neutral

Transcript signals

Read full transcript analysis ›